PRAVASTATIN SODIUM
NDC 69097-791, PRAVASTATIN SODIUM, tablet, from CIPLA USA INC..
- Product NDC
- 69097-791
- Status
- Listed
- Labeler
- CIPLA USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077987
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-791 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRAVASTATIN SODIUM40 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-791-05 | 69097079105 | 90 TABLET in 1 BOTTLE (69097-791-05) |
| 69097-791-12 | 69097079112 | 500 TABLET in 1 BOTTLE (69097-791-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/678dfe58-3200-4c3d-9718-365aa47d070fNADAC price for package 69097079105
GET /v1/drugs/nadac/69097079105NADAC price for package 69097079112
GET /v1/drugs/nadac/69097079112
Use it
Look up 69097-791 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-791 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-791. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.